Vivos Therapeutics (VVOS) Other financing activities (2023 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Other financing activities of $567000.0 for Q1 2026, up 168.07% quarter-over-quarter from -$833000.0 in Q3 2025.
Vivos Therapeutics (VVOS) Other financing activities (2023 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Other financing activities for 4 consecutive years, with $567000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities changed N/A year-over-year to $567000.0; the TTM figure through Mar 2026 stood at $3.2 million (changed N/A YoY), while the FY2025 annual figure was $866000.0, down 88.45% from the prior year.
- Other financing activities climbed to $567000.0 in Q1 2026 per VVOS's latest filing, from -$833000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $8.0 million in Q1 2023 and bottomed at -$833000.0 in Q3 2025.
- Historically, Other financing activities has averaged $3.2 million across 4 years, with a median of $3.6 million in 2024.
- On a YoY basis, Other financing activities climbed as much as 12.5% in 2024 and fell as far as 50.74% in 2024.
- Vivos Therapeutics' Other financing activities stood at $4.0 million in 2023, then retreated by 12.5% to $3.5 million in 2024, then tumbled by 123.8% to -$833000.0 in 2025, then surged by 168.07% to $567000.0 in 2026.
- Business Quant data shows VVOS's Other financing activities at $567000.0 in Q1 2026, -$833000.0 in Q3 2025, and $3.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 567,000.00 |
| Mar 31, 2026 | 567,000.00 |
| Sep 30, 2025 | -833,000.00 |
| Sep 30, 2025 | -833,000.00 |
| Dec 31, 2024 | 3.50 Mn |
| Dec 31, 2024 | 3.50 Mn |
| Jun 30, 2024 | 3.56 Mn |
| Jun 30, 2024 | 3.56 Mn |
| Mar 31, 2024 | 3.94 Mn |
| Mar 31, 2024 | 3.94 Mn |
| Dec 31, 2023 | 4.00 Mn |
| Dec 31, 2023 | 4.00 Mn |
| Mar 31, 2023 | 8.00 Mn |
| Mar 31, 2023 | 8.00 Mn |